Chicago Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,636
Closed -$1.28M 362
2025
Q4
$1.28M Sell
12,636
-105
-0.8% -$8.43K 0.03% 178
2025
Q3
$697K Sell
12,741
-1,172
-8% -$58.6K 0.02% 221
2025
Q2
$739K Sell
13,913
-55
-0.4% -$2.79K 0.02% 215
2025
Q1
$605K Buy
13,968
+3,888
+39% +$197K 0.02% 222
2024
Q4
$566K Buy
10,080
+5,629
+126% +$350K 0.02% 215
2024
Q3
$303K Buy
+4,451
New +$251K 0.01% 264
2024
Q2
Sell
-4,451
Closed -$307K 310
2024
Q1
$307K Hold
4,451
0.01% 254
2023
Q4
$329K Hold
4,451
0.01% 231
2023
Q3
$304K Hold
4,451
0.01% 188
2023
Q2
$418K Hold
4,451
0.02% 170
2023
Q1
$302K Hold
4,451
0.02% 190
2022
Q4
$220K Buy
+4,451
New +$182K 0.01% 208
2022
Q2
Sell
-4,451
Closed -$311K 248
2022
Q1
$311K Hold
4,451
0.01% 211
2021
Q4
$346K Hold
4,451
0.01% 204
2021
Q3
$425K Hold
4,451
0.02% 189
2021
Q2
$553K Hold
4,451
0.02% 169
2021
Q1
$587K Buy
+4,451
New +$609K 0.02% 162

Other funds holding EXAS

Chicago Capital's EXAS Position: Q1 2026 in Review

Chicago Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12,636 shares — an estimated $1.28M sold.

Chicago Capital first reported a position in EXAS in Q1 2021 and held it in 17 quarters. The position peaked at $1.28M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Chicago Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Chicago Capital sold 12,636 Exact Sciences shares in Q1 2026, an estimated $1.28M.
  • Chicago Capital first reported a position in Exact Sciences in Q1 2021 and held it in 17 quarters.
  • Chicago Capital's Exact Sciences position peaked at $1.28M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Chicago Capital's 13F filing for Q1 2026, filed 24 Apr 2026.